Companies: 48,686 Total Market Cap: 191185238948751.54

Cardio Diagnostics Holdings

NASDAQ: CDIO
Healthcare Biotechnology
Rank #40276
Market Cap 8.20 M
Volume 143,467
Price 0.16
Change (%) 15.02%
Country or region United States United States

Cardio Diagnostics Holdings's latest marketcap:

8.20 M

As of May 13, 2025, Cardio Diagnostics Holdings's market capitalization has reached $8.20 M. According to our data, Cardio Diagnostics Holdings is the 40276th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 8.20 M
Revenue (ttm) 34,890
Net Income (ttm) -8,383,453
Shares Out 52.15 M
EPS (ttm) -9.35
Forward PE 0.00
Ex-Dividend Date n/a
Earnings Date May 23, 2025
Market Cap Chart
Data Updated: May 13, 2025

Cardio Diagnostics Holdings's yearly market capitalization.

Cardio Diagnostics Holdings has seen its market value drop from $10.09 M to $8.20 M since 2022, representing a total decrease of 18.67% and an annual compound decline rate (CAGR) of 8.35%.
Date Market Cap Change (%)
May 13, 2025 $8.20 M -73.97%
December 31, 2024 $37.08 M -27.41%
December 29, 2023 $51.09 M 406.53%
December 30, 2022 $10.09 M

Company Profile

Cardio Diagnostics Holdings was founded in 2017 in United States. on the Nasdaq Stock Market. With 15 employees, it focuses on Healthcare and aims to drive innovation in Biotechnology.
Frequently Asked Questions

As of May 13, 2025, Cardio Diagnostics Holdings (including the parent company, if applicable) has an estimated market capitalization of $8.20 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Cardio Diagnostics Holdings global market capitalization ranking is approximately 40276 as of May 13, 2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region United States
Founded 2017
IPO Date n/a
Employees 15
CEO
Sector Healthcare
Industry Biotechnology
Address